Interpace Biosciences, Inc.
IDXGD
$6.98
-$0.02-0.29%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.69M | 2.65M | 2.51M | 1.42M | 502.00K |
| Total Receivables | 6.31M | 5.93M | 5.65M | 5.97M | 7.23M |
| Inventory | 1.09M | 961.00K | 1.11M | 1.10M | 973.00K |
| Prepaid Expenses | 696.00K | 430.00K | 632.00K | 584.00K | 730.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 188.00K | -- | -- | 53.00K | 68.00K |
| Total Current Assets | 10.97M | 9.96M | 9.90M | 9.13M | 9.50M |
|
|
|||||
| Total Current Assets | 10.97M | 9.96M | 9.90M | 9.13M | 9.50M |
| Net Property, Plant & Equipment | 2.62M | 2.43M | 2.64M | 2.86M | 2.79M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.96M | 21.02M | 21.30M | 45.00K | 45.00K |
| Total Assets | 34.55M | 33.41M | 33.84M | 12.04M | 12.34M |
|
|
|||||
| Total Accounts Payable | 1.56M | 805.00K | 983.00K | 1.41M | 1.25M |
| Total Accrued Expenses | 2.04M | 1.77M | 2.70M | 2.26M | 2.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 458.00K | 445.00K | 431.00K | 1.40M | 2.18M |
| Total Finance Division Other Current Liabilities | 896.00K | 946.00K | 991.00K | 881.00K | 883.00K |
| Total Other Current Liabilities | 896.00K | 946.00K | 991.00K | 881.00K | 883.00K |
| Total Current Liabilities | 4.95M | 3.96M | 5.10M | 5.95M | 7.15M |
|
|
|||||
| Total Current Liabilities | 4.95M | 3.96M | 5.10M | 5.95M | 7.15M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 516.00K | 635.00K | 752.00K | 864.00K | 974.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.84M | 5.73M | 5.62M | 5.53M | 5.43M |
| Total Liabilities | 11.31M | 10.33M | 11.48M | 12.33M | 13.55M |
|
|
|||||
| Common Stock & APIC | 235.25M | 235.24M | 235.24M | 235.24M | 235.23M |
| Retained Earnings | -209.93M | -210.08M | -210.81M | -233.46M | -234.37M |
| Treasury Stock & Other | -2.08M | -2.08M | -2.07M | -2.07M | -2.07M |
| Total Common Equity | 23.24M | 23.08M | 22.36M | -298.00K | -1.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.24M | 23.08M | 22.36M | -298.00K | -1.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.24M | 23.08M | 22.36M | -298.00K | -1.21M |
|
|
|||||